ArticleBMC surgery2025
Serum calprotectin as a biomarker for postoperative complications in colorectal surgery: a pilot study defining normal postoperative dynamics.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposesPostoperative infections are the common cause of morbidity and mortality in colorectal surgery. Calprotectin, an S100 protein, may be a potential marker. The aim was to define the postoperative course (PC) of calprotectin in serum (CIS), compared to white blood cell (WBC), C-reactive protein (CRP), lactate and procalcitonin (PCT).
methodsThis prospective, single-center study measured all biomarkers preoperatively, on the first, third and fifth postoperative days (POD). The endpoint was the PC of CIS compared to the WBC, CRP, PCT, and lactate. CIS between benign and malignant disease and between patients with and without complications was compared. Also a correlation was carried out.
results56 patients (14 rectum, 42 colon) were included. The postoperative CIS increased to preoperative values (p < 0.05). The preoperative CIS in malignant disease was higher (p < 0.05). CIS on the first and fifth POD was higher in the group with complications (p < 0.05). CIS and CRP, WBC and CRP on the third POD (p < 0.05) correlate in complications .
conclusionWe present the normal course of CIS and its potential function as a marker for systemic inflammation. We showed that postoperative CIS were significantly higher in complications. Although our study has several limitations, - namely a small sample size and heterogeneous surgical procedures -, serum calprotectin may be an interesting biomarker for future larger studies, particularly due to its increased specificity for intestinal inflammation.
trial registrationThis study is prospectively registered in DRKS-ID (Deutsches Register Klinischer Studien, German WHO Register): DRKS00027142, data of registration 29.11.2021. This is a WHO-recognized primary registry that meets the requirements of the International Committee of Medical Journal Editors (ICMJE). We registered this study in the DKG (Deutsche Krebsgesellschaft) Sudybox ST-D512, data of registration 11.03.2022.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.